Meeting
2020 ASCO Virtual Scientific Program
Genomic and transcriptomic profiles of gynecologic neuroendocrine carcinoma are distinct from pulmonary neuroendocrine small cell carcinoma.
Authors
Haider Mahdi
Cleveland Clinic, Cleveland, OH
Haider Mahdi , Amy Joehlin-Price , Afshin Dowlati , Ata Abbas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Other Gynecologic Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 6093)
DOI
10.1200/JCO.2020.38.15_suppl.6093
Abstract #
6093
Poster Bd #
264
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Genomic analysis and prediction of therapeutic vulnerabilities of small cell lung cancer from rovalpituzumab tesirine phase III trial (MERU).
First Author: Weilong Zhao
Poster
2021 ASCO Annual Meeting
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
First Author: Chul Kim
Poster
2021 ASCO Annual Meeting
Real-world multiomic characterization of small cell lung cancer subtypes to reveal differential expression of clinically relevant biomarkers.
First Author: Sonam Puri
Poster
2023 ASCO Annual Meeting
Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer.
First Author: Anne C. Chiang